The hospital is a doctoral program in clinical medicine, a post-doctoral research station in clinical medicine, and a doctoral and master's degree awarding point in clinical medicine. The First Clinical Medical College of Nanjing Medical University is located in the hospital, with 5 departments and 45 teaching and research sections, and undertakes the clinical teaching and internship tasks of Nanjing Medical University.
The Plastic Burn Department of Jiangsu Provincial Hospital is a professional department integrating clinical medical treatment, teaching and scientific research, with doctors with bachelor degree or above 14. Among them, there are 2 chief physicians, 6 deputy chief physicians, 4 doctors and 2 masters. The members of the department are young and middle-aged members of Medical Beauty Branch of Chinese Medical Association, members of Burn Branch of Chinese Society of Integrated Traditional Chinese and Western Medicine, members of First Aid and Treatment Group of Multiple Injuries and Compound Injuries of Trauma Branch of Chinese Medical Association, vice-chairman and members of Plastic Burn Branch of Jiangsu Province, director of Jiangsu Rehabilitation Medical Association, secretary-general and standing committee member of Repair and Reconstruction Branch, and vice-chairman of Medical Beauty Branch of Nanjing Medical Association. Deputy director of Medical Aesthetics and Beauty Branch of Jiangsu Medical Association, member of Burn Society in six provinces and one city in East China, and deputy director of Medical Tissue Engineering and Transplantation Committee of Jiangsu Biomedical Engineering Society.
The Plastic Burn Department of Jiangsu Provincial Hospital has advanced hammock for burn treatment, Zimmer electric peeling machine, special soaking equipment for burns, heavy electronic body for burns, flap Doppler blood flow meter, peeling machine, red light therapeutic instrument and electric negative pressure liposuction machine. It has a professional camera room and an independent outpatient cosmetic operating room and surgical design software system.
List of Hospital Departments Internal Medicine Cardiovascular Department Respiratory Department Endocrinology Department Hematology Department Gastroenterology Department Nephrology Department Rheumatology Immunology Department Infectious Diseases Department Oncology Department Dermatology Department General Internal Medicine (General Internal Medicine) Surgery Anesthesiology Department ICU Orthopedic Thoracic Surgery Cardiovascular Surgery General Surgery General Surgery Liver Surgery Urology Neurosurgery Plastic Burn Department Otolaryngology Department Ophthalmology and Stomatology Department Breast Department (General Surgery) Geriatrics ICU Elderly CCU Elderly Nephropathy Elderly Cardiovascular Department Elderly Neurology Elderly Gastroenterology Elderly Endocrinology Elderly Comprehensive Ward Elderly Diagnosis and Treatment Physical Examination Department Rehabilitation Medicine Department Obstetrics and Gynecology Obstetrics Reproductive Medicine Center Women's Health Department Pediatrics and Children's Health Department Emergency Chinese Medicine Acupuncture Department Clinical Psychology Department Medical Technology Pharmacy Laboratory Radiology Interventional Radiography Diagnosis Department Pathology Department Nuclear Medicine Nutrition Department Blood Transfusion Department HLA Laboratory, Radiotherapy Department, Diagnosis and Treatment Center, Pancreas Center, Digestive Endoscopy Center, Liver Transplantation Center, Rehabilitation Center, Intensive Care Center, Coronary Center, Reproductive Medicine Center, Judicial Appraisal Institute, Infectious Diseases Department of the First Affiliated Hospital of Jiangsu Province and Nanjing Medical University (formerly Infectious Diseases Department) were established in 1954. Under the leadership of famous tropical pathologists Professor Xu Benqian, Chen Zhongying, Jia Fuzhong, Wang, Tang Baoyuan and Huang Zuhu, after decades of hard work, we have made remarkable achievements in the diagnosis and treatment of common major infectious diseases, clinical teaching, scientific research, personnel training and discipline construction, and 200 1 was awarded as the key discipline of clinical medicine in Jiangsu Province, which is the only one in Jiangsu Province at present.
At present, infectious diseases department has fever clinic, hepatitis clinic and intestinal clinic, with an annual outpatient volume of nearly 40 thousand, and experts sit in the clinic all the year round. There are two wards in the ward, with more than 50 beds, and more than 200 patients are discharged every year/kloc-0. Nearly half of the inpatients are from other places, including difficult and critical patients in primary hospitals in other provinces and cities, which fully reflects the recognition and trust of peers to improve the medical level and overall strength of the department. In addition to rich experience and high level in the diagnosis and treatment of viral hepatitis, our department has also made great progress and made some breakthroughs in the diagnosis and treatment of fever to be investigated, serious infection, various liver diseases and multiple organ failure in recent years. Many patients with complex infection and severe liver disease were successfully rescued, such as severe tuberculous meningoencephalitis complicated with type II respiratory failure, subacute liver failure complicated with brain abscess, lung infection, virus infection complicated with multiple organ dysfunction syndrome, hyperthyroidism complicated with severe hepatitis, etc. The successful treatment of these diseases not only saved the lives of patients, but also improved the diagnosis and treatment level of general practitioners and the academic status of departments.
Today's infectious diseases department has excellent facilities, spacious and bright outpatient hall, quiet and warm ward, advanced intensive care unit, fully functional artificial liver support system, cell therapy room built according to GLP standards, modern teaching facilities and newly equipped infection and immunity laboratory, which provide good conditions for the all-round development of infectious diseases department. There are more than 50 beds in the department, with nearly 40,000 outpatient visits in the past three years and annual hospitalization visits 1 10,000. There are many famous infectious disease experts in the province and even the whole country, including 2 doctoral supervisors and 7 master supervisors. Among the professionals, there are 2 professors, 5 associate professors, provincial 333 program trainees 1 person, Jiangsu "Xingwei Project" key talents 1 person, doctors or masters 13 people, among whom 8 people have studied in the United States, Australia, Japan and Germany.
Infectious diseases department is the first master's degree awarding point in Chinese universities, the earliest doctor's degree awarding point in internal medicine infectious diseases in our province, and the anti-infection specialty of drug clinical trial institutions approved by SFDA. It is also a training base for infectious diseases specialists, and undertakes multi-level higher medical teaching tasks with undergraduate and postgraduate teaching as the main tasks. The discipline was approved as a key clinical specialty in Jiangsu Province on 1997, as a key clinical medicine discipline in Jiangsu Province on 200 1 and as a key infectious disease discipline in Jiangsu Province in 2007.
This discipline is characterized by the diagnosis and treatment of various liver diseases and infectious diseases, and chooses the treatment of viral hepatitis as the main development direction, focusing on the specific cell biotherapy of chronic viral hepatitis, the establishment of new comprehensive treatment for severe hepatitis and the research and development of therapeutic nucleic acid vaccine for chronic hepatitis B, and jointly establishing the "China-US Vaccine Research Center" with the Gene Vaccine Laboratory of the University of Massachusetts Medical College. Jiangsu Provincial Hospital (the First Affiliated Hospital of Nanjing Medical University) has more than 100 employees, including 5 with senior title/kloc-0 and 50 with intermediate title. In the whole year, 65,438 0.66 thousand prescriptions were prescribed for emergency treatment, 565,438 0.68 TDM monitoring were completed, ADR 946 ADR cases were reported.
This discipline took the lead in monitoring therapeutic drugs in the province and established the first drug intravenous dispensing center in Jiangsu Province. We have successively set up an adverse drug reaction monitoring office, an office for rational use of antibacterial drugs and an outpatient drug consultation desk to carry out the work of clinical pharmacists, provide patients with appropriate therapeutic drugs and the best administration scheme, undertake the phase I clinical pharmacokinetics of new drugs, and assist in clinical monitoring, clinical drug evaluation, new drug trials and efficacy evaluation of therapeutic drugs. This subject has won 2 science and technology funds from the Ministry of Health, 2 from Jiangsu Province, 9 from the Health Department of Jiangsu Province, and 4 from Southern Medical University. The Medical Laboratory Department of Jiangsu Provincial Hospital (the First Affiliated Hospital of Nanjing Medical University) is a key clinical specialty in Jiangsu Province, with doctoral and master's programs. There are more than 7 1 staff, including 5 senior titles1staff and 33 intermediate titles. The total area of the existing laboratory is 2500M2.
This department is an important part of Jiangsu Medical Diagnosis Center supported by Jiangsu provincial government. There are clinical hematology, clinical biochemistry, clinical immunology, clinical microbiology and clinical molecular biology diagnostic laboratories, and nearly 800 routine and special clinical examination and diagnosis projects are carried out. In 2002, it was recognized as the only provincial clinical key specialty (medical laboratory) in Jiangsu Province at that time. In recent years, he has obtained 6 research projects, applied for 2 national technology invention patents, won 2 provincial achievement awards independently or participated in, and edited 10. Publish 30 academic papers every year. The Department of Pathology of the First Affiliated Hospital of Nanjing Medical University was established in 1962, with Professor Gundam as the director of the Pathoanatomy Department of Nanjing Medical College, Gu as the deputy director and Xu Qinan as the second deputy director of the affiliated hospital. At the beginning of the establishment of the department, the teaching and research group of pathological anatomy of medical college sent medical technicians to the department in turn to carry out daily pathological work. 1965 added 2 technicians, 1972 added residents 1 person. 1977, Xu Qin was appointed as the director of the security department, and the number of personnel was increasing. 1in the summer of 984, Kaiping was appointed as the deputy director. After 1988, Fan Qin was appointed as the deputy director.
The Department of Pathology is a master's and doctor's degree program of clinical pathology authorized by Nanjing Medical University. At present, there are 26 staff members, including 6 senior titles, 2 intermediate titles/kloc-0 and 8 junior titles. In recent years, more than 40,000 cases of surgical pathological examination, cytological examination 1000 cases, TCT 1500 cases, 2000 cases of immunohistochemistry, 2000 cases of rapid freezing diagnosis, 5000 cases of pathological consultation and 20 cases of autopsy have been completed every year. He has undertaken 5 projects above the provincial level, published more than 60 papers and 2 monographs, and won 2 awards above the provincial level. In recent years, the Department of Pathology has trained more than 0/0 doctors and postgraduates/kloc, and more than 0/00 senior doctors/kloc inside and outside the province. Since 2007, our department has received more than 10 interns and technicians. Nutrition department is affiliated to the medical technology department of the hospital, and it is the clinical nutrition teaching and research section of the First Clinical Medical College of Nanjing Medical University. Chief nutritionist, deputy chief nutritionist, nutritionist and nutrition nurse who have been engaged in clinical nutrition for many years 10. Responsible for hospital nutrition therapy, outpatient consultation, teaching and scientific research.
Over the years, while strengthening the infrastructure and management of the department, the Nutrition Department has been making continuous progress and innovation, undertaking nutrition consultation for patients with diabetes, hypertension, hyperlipidemia, obesity, kidney diseases, hepatobiliary and pancreatic diseases, and before and after surgery, putting forward nutrition treatment plans according to the illness, and carrying out nutrition education, which has played an important role in promoting the treatment and rehabilitation of diseases. Actively cooperate with clinical departments to provide nutritional support for severe, difficult and organ transplant patients; In today's society with increasing health awareness, we should make use of the advantages of departments and professional expertise to carry out nutrition and chronic disease intervention research. Establish nutrition clinics and expert clinics to provide nutrition consultation and nutrition intervention for all kinds of people with nutritional needs, which really plays a role in preventing and treating diseases and improving health. The blood transfusion department was established in 2003, and has changed from a single-function blood bank to a comprehensive department involving multiple disciplines and technologies. Its main function is to be responsible for the technical implementation and guidance of clinical blood use, and to ensure the implementation of blood supply, blood storage, blood matching and scientific and rational blood use measures. Monitoring and preventing transfusion-transmitted diseases; Responsible for clinical blood consultation in the whole hospital; Carry out therapeutic blood transfusion and hematopoietic stem cell research such as hematopoietic stem cell apheresis and plasma exchange.
At present, the blood transfusion department covers an area of 200 square meters, with functional rooms such as blood storage room, blood type room, blood matching room, treatment room, blood delivery room and reference room. The existing staff 12 people have been trained in blood transfusion theory and experimental technology, graduated from medicine and laboratory, and have professional titles. Among them, there are 2 masters, 7 undergraduates, 2 senior titles, 5 intermediate titles and 5 junior titles. In recent years, the concept of blood transfusion has been updated, and component blood transfusion has been vigorously promoted. The proportion of component blood transfusion reached more than 90%, far exceeding the requirements of the third-class first-class hospital of the Health Department of the Ministry of Health (70% of blood components). The annual blood consumption of our hospital is more than 6.5438+0.8 million milliliters, ranking first in the province. The blood components provided by our department for clinic include red blood cell suspension, leucopenia red blood cell suspension, washed red blood cells, irradiated red blood cells, apheresis platelets, cold precipitation, fresh frozen plasma and ordinary frozen plasma. Blood transfusion department includes Guangzhou Road Headquarters and Jiangdong North Road Hexi Branch, all of which provide 24-hour clinical services.
At present, the services include ABO blood group and Rh blood group detection, irregular antibody screening and titer determination, cross matching, routine examination before blood transfusion, difficult blood group identification, prenatal laboratory diagnosis of neonatal hemolysis, autologous blood transfusion and peripheral blood stem cell collection. Our department took the lead in introducing imported anti-human ball microcolumn gel technology, cross matching and blood type automatic sampling system in Jiangsu Province, and established an all-round blood transfusion information management system. The information technology and level of blood transfusion are advanced in Jiangsu Province and East China, which not only ensures the safety of routine blood use and rare blood group and difficult cases, but also completes the mobilization and collection of dozens of volunteers before donation as one of the designated collection units of peripheral blood hematopoietic stem cells in Jiangsu Branch of China Bone Marrow Bank.
The blood transfusion department is currently the chairman of the Jiangsu Provincial Clinical Blood Transfusion Committee. 200 1 Up to now, it has undertaken 4 provincial and ministerial projects, participated in 2 academic institutions, and published more than 40 core journal papers, including 7 in SCI. International cooperation with forest law enforcement and governance organizations is under way. WA, a blood group expert from university of ulm, Germany, gave a research topic on "Rh(D) negative genotyping and genetic distribution". He undertook the theoretical teaching of clinical blood transfusion specialty in the medical laboratory department of Nanjing Medical University and the internship teaching tasks in other medical colleges.
Blood transfusion department firmly establishes the consciousness of "quality is life", improves the quality management system of the department, and strengthens the quality and discipline construction in all directions. Provide safe, timely and effective services for clinic. The department of ultrasound diagnosis was established in 1 June 19821,and was renamed as the department of ultrasound medicine in 200 1. There are 3 chief physicians, 3 deputy chief physicians and 4 attending physicians in the department. There are 3 associate professors, 3 lecturers and 3 masters. * * * Ultrasound Clinician 15 people, including 5 graduate students and 4 master students. Make an appointment to register two people, one of whom is the main nursing department and interventional therapy and nursing work. Professor Hu Jianqun, the current director, is a master tutor of the Department of Imaging Medicine of Nanjing Medical University, a director of the Chinese Society of Ultrasound Medical Engineering, a member of the National Standing Committee of the Superficial Small Organs and Peripheral Vessels Ultrasound Professional Committee of the Chinese Society of Ultrasound Medical Engineering, a member of the Ophthalmology Professional Committee, a vice president of the Jiangsu Society of Ultrasound Medical Engineering, a director of the Jiangsu Society of Acoustics, and a deputy head of the abdominal ultrasound professional group. Associate Professor Wang Huining is the vice chairman of the Ultrasound Medical Branch of Nanjing Medical Association; Ye Xinhua, deputy director, tutor of seven-year postgraduate students of Nanjing Medical University, permanent member of China Ultrasound Medical Engineering Society, member of musculoskeletal ultrasound professional committee of China Ultrasound Medical Engineering Society, and member of interventional ultrasound professional committee of China Medical Imaging Technology Research Association.
The Department of Ultrasound Diagnosis, Department of Imaging, Nanjing Medical University is also a provincial training base for ultrasound doctors, which completes 320 hours of teaching for undergraduate, junior and senior doctors of imaging every year. He has undertaken 4 provincial-level projects, edited or edited ultrasound monograph 15, published dozens of papers in magazines above the provincial level, won the second prize of China Medical Science and Technology Award during the Tenth Five-Year Plan period, won the first prize of provincial scientific and technological progress, won the second prize of new technology introduction of provincial health department, and won the first prize, second prize and encouragement prize of new technology in hospital diagnosis and treatment. Independently obtained Jiangsu Natural Science Fund 1, Nanjing Medical University Innovation Fund 1, Institute Innovation Fund 3, and participated in many projects. In addition to completing more than 10 thousand routine tasks such as abdomen, superficial small organs and peripheral blood vessels every year, we also carry out puncture, drainage, decompression and sclerotherapy of various cysts; Ultrasound-guided puncture drug therapy for thyroid adenoma and thyroiditis: anhydrous alcohol therapy for liver cancer, microwave and radio-frequency ultrasound-guided therapy for liver tumors, ultrasound-guided tissue biopsy of various tumors, observation of morphology and blood supply during and after liver transplantation and other new technologies and projects. Abdominal and small organ ultrasound undertakes the task of consultation in the whole province. The academic level of ultrasound medicine has always been in the leading position in the province and advanced in China. 1, cardiac electrophysiology technology
Study on the pathogenesis and interventional diagnosis and treatment of ventricular arrhythmia: the animal model of ventricular arrhythmia caused by ischemic heart disease was successfully established and the intervention study of stem cell transplantation was carried out; The number of cases of malignant ventricular arrhythmia treated by radiofrequency ablation of ventricular tachycardia and intracardiac cardioverter defibrillator and their academic places in this field rank in the top two in China. Clinical application of three-dimensional mapping system: The pathological matrix and electrophysiological mechanism of arrhythmia were studied by using three-dimensional mapping system (EnSite 3000/Navx). According to the principle of dynamic matrix mapping, a new strategy of linear ablation under sinus rhythm is designed, which significantly improves the success rate of refractory ventricular tachycardia. Clinical diagnosis of cardiac ion channel diseases: A new diagnostic method for recessive Brugada syndrome and congenital QT interval prolongation syndrome was studied and established.
2, ischemic heart disease, congenital heart disease and valvular disease diagnosis and treatment technology.
Biotherapy and interventional therapy of ischemic heart disease: Adenovirus-mediated VEGF 165, angiopoietin-1 biotherapy and stem cell transplantation were carried out earlier in China. Monoclonal antibodies against cardiac troponin I were prepared and obtained, and two national patents and 1 second class new drug certificates were obtained. Interventional treatment of congenital heart disease and valvular disease: Interventional treatment of ventricular septal defect was carried out earlier in China; Independently designed and completed the preparation of minimally invasive catheter self-expanding trilobal aortic biological valve device, designed and completed the occluder which can be automatically positioned in the left atrial appendage, and won 2 national patents.
3. Molecular and cellular mechanisms of cardiovascular diseases.
Study on the etiology and pathogenesis of myocarditis and cardiomyopathy: 1986 Jiangsu Cardiomyopathy Research Base has been established, and the National Cardiomyopathy Research Collaboration Group has been established. Study on the function of vascular endothelium and smooth muscle: it is proved that endothelial contraction factor is a kind of diffusive and transmissible substance, and one of its targets is vascular smooth muscle; It is found that resveratrol can effectively inhibit the proliferation of vascular smooth muscle cells and intimal hyperplasia after vascular endothelial injury.
4. Epidemiology of risk factors related to cardiovascular diseases.
To study the epidemiological characteristics of risk factors related to cardiovascular diseases and the prevention and treatment effect of multi-factor comprehensive intervention at the population level; Organized and participated in a number of national and provincial cardiovascular epidemiological studies, participated in a number of international multi-center clinical trials, and accumulated rich epidemiological research experience. [2] Combined with the discipline foundation and clinical needs, general surgery has made outstanding achievements in basic and clinical research such as organ transplantation, minimally invasive surgery, pancreatic surgery, breast surgery, etc., and has formed its own characteristics, which has certain influence at home and abroad and reached the international leading level in some aspects.
1, liver transplantation technology
In 2005, Jiangsu Hepatology Surgery Center established China Living Donor Liver Transplantation Institute, which was listed by the Ministry of Health. It consists of 2 wards, 100 beds and 1 experimental center, forming a strong support for clinical and scientific research. It has become one of the units that can independently carry out living donor liver transplantation and form a certain scale in China. 79 cases of living donor liver transplantation have been completed, which is one of the units with the largest number of cases in China. At present, 40 patients with hepatolenticular degeneration have received living relative liver transplantation, which is the largest, most systematic and in-depth single-center case report in the world. So far, more than 4,500 patients have undergone hepatectomy for liver cancer. 1, 3-and 5-year survival rates were 89.2%, 50.4% and 33.3%, respectively, and more than 60 patients survived over 10 year.
2. Laparoscopic technique
Establish the first batch of endoscopic surgery technical training bases certified by Chinese Medical Association. Laparoscopic choledocholithotomy, splenectomy, radical resection of gastrointestinal tumor, thyroidectomy, total parathyroidectomy, pancreaticoduodenectomy, insulinoma resection, fundoplication, Roux-en-Y cholangiojejunostomy, portal azygos devascularization and many other operations have been carried out successively. More than 4,000 cases of ERCP and EST have been successfully carried out, ranking among the top in China in terms of the complexity, diversity, quality and quantity of operations and the success rate of operations.
3, tumor radio frequency therapy technology
A systematic and in-depth study is carried out around the RFA field. Excellent achievements have been made in electrode optimization, image organization correspondence and experimental methodology. In cooperation with enterprises, we developed a radio frequency tumor therapeutic instrument with independent intellectual property rights and technical patents in China, and in 2005, it was approved by the state for mass production and clinical application. In clinical application, it is one of the first few units in China to apply this technology to the treatment of liver cancer, lung cancer, kidney cancer and intracranial tumors. Assist neurosurgery to apply RFA technique for the first time in the world to remove huge intracranial hemangioma that cannot be removed by conventional surgery. "Experimental and clinical research on radio frequency inactivation of solid tumors" won the first prize of Jiangsu provincial government for scientific and technological progress in 2006.
4, pancreatic disease diagnosis and treatment technology
"Pancreatic Disease Diagnosis and Treatment Center" is one of the five major pancreatic surgery centers in China. It is in a leading position in the diagnosis and treatment of severe acute pancreatitis and pancreatic cancer in China; Laparoscopic pancreaticoduodenectomy, insulinoma resection, pancreatic pseudocyst internal drainage, and pancreatic body and tail resection are the first in the province, all of which are advanced in China. The quantity and quality of operations have entered the domestic advanced ranks. Simultaneous pancreas-kidney transplantation was first carried out in the province, which is advanced in China. As the main cooperative unit, I participated in the sub-project "Study on the Comprehensive Treatment Technology System of Pancreatic Cancer", a major scientific and technological support project of the Ministry of Science and Technology in the Eleventh Five-Year Plan.
5, breast disease diagnosis and treatment technology
The research on sentinel lymph node biopsy and micrometastasis of breast cancer is in the forefront of domestic counterparts, and the research on "breast cancer stem cells" and "the function of neocytidine deaminase hDCA gene in breast cancer" is carried out. He applied for two national invention patents, namely, "A new method for separating breast cancer stem cells" and "Animal model of bone metastasis", and pioneered a new technology of microwave coagulation for the treatment of breast tumors. The national tenth five-year plan key project "prospective multicenter study on standardized breast-conserving comprehensive treatment for early breast cancer" has been completed. 1. Basic and clinical study of bronchial asthma
For decades, the department has been focusing on the research of bronchial asthma, doing a lot of basic and clinical research, forming its own characteristics of diagnosis and treatment, reaching the leading level in China. In recent years, the mechanism of airway inflammation in asthma and new methods of noninvasive diagnosis and clinical intervention have been deeply studied, and the results are remarkable: "β2 receptor abnormality in patients with bronchial asthma and its clinical significance" won the second prize of provincial scientific and technological progress; "Experimental research on diagnosis and treatment of bronchial asthma" won the third prize of provincial scientific and technological progress; "Experimental and Clinical Research on Airway Inflammation of Bronchial Asthma" won the third prize of medical science and technology in China and the second prize of scientific and technological progress in Nanjing. He has presided over 3 national natural science foundations, undertaken more than provincial and ministerial projects 10, published more than 200 related papers (including 4 in SCI 10), and participated in more than 0 international seminars10. In recent 8 years, we have taken the lead in organizing "Nanjing Asthma Home" to prevent and treat asthma, and achieved good results. Many patients with refractory asthma from other provinces come to our clinic or hospital for treatment.
2. Pathogenesis, diagnosis and treatment of sleep-disordered breathing.
The Sleep Respiratory Disorder Diagnosis and Treatment Center was established in 200 1, and it has purchased international advanced equipment such as multi-channel sleep monitor, PTT sleep respiratory monitor, plasma low-temperature radiofrequency ablation instrument and supporting servo automatic positive airway pressure ventilator. Every year, more than 1000 patients with sleep disorders are successfully diagnosed and treated, and more than 50 papers (including 8 SCI papers) have been published in domestic and foreign magazines, winning the domestic and foreign award 10, which is highly concerned and praised by colleagues at home and abroad. Undertaking the provincial international cooperation project 1, presiding over and participating in the national natural science foundation project 1, and presiding over two international seminars on sleep and respiratory disorders. The technical feature of our department in this field is the correlation between sleep apnea syndrome and cardiovascular diseases and a series of studies on intervention and treatment. The medical and scientific research work in this field has reached the domestic advanced level.
3. Diagnosis, treatment and research of respiratory infectious diseases
The department has accumulated rich experience in respiratory infectious diseases, and the clinical diagnosis rate and cure rate are high. Professor Yin Kaisheng is a member of the national anti-infection group and the deputy head of the lung infection cooperation group in East China. During the period of SARS in 2003, Professor Yin Kaisheng served as the head of the expert group on prevention and treatment of SARS in Jiangsu Province, and Professor Huang Mao served as the head of the expert group on prevention and treatment of SARS in Inner Mongolia, Jiangsu Province, with outstanding achievements, both of which were commended by the state and provincial governments. Prevention and treatment of atypical pneumonia, edited by our department, won the National Book Award and the Handbook of Practical Anti-infective Drugs (People's Health Publishing House), which was widely praised. He presided over 42 clinical studies of new anti-infective drugs, all of which were successfully certified. In recent years, respiratory syncytial virus has been studied experimentally.
4. Pathogenesis and treatment of pulmonary hypertension.
Pulmonary hypertension, as a key pathophysiological link from COPD to cor pulmonale, is an important factor affecting the prognosis of COPD. Participated in six national sub-projects of "1035" and the project of Jiangsu Science and Technology Department, "Effect of ATP-sensitive potassium channel opener on the occurrence and development of pulmonary hypertension and its treatment research" (200005 1). * * * published more than 40 papers. In 2007, he won the third prize of Chinese medical science and technology, the first prize of outstanding papers of young and middle-aged people in China, the annual prize of Dr. China Seckler, the third prize of national scientific and technological progress, the second prize of scientific and technological progress of the State Administration of Medicine and the second prize of Jiangsu Province.
5. Diagnosis and treatment of respiratory endoscopy
The department carried out lung biopsy through bronchoscope, bronchoalveolar lavage, fiberoptic bronchoscopy instead of thoracoscopic diagnosis and treatment, stent implantation under bronchoscope, needle aspiration biopsy through bronchoscope, thoracoscopic diagnosis and treatment, and high-frequency electrosurgery under fiberoptic bronchoscope earlier in the province. In 2007, he was awarded the project of Jiangsu Provincial Health Department, "Study on the application of lung volume reduction with fiberoptic bronchoscope stent in the treatment of emphysema model". In 2007, respiratory endoscopy center was rated as the national training base of endoscopic diagnosis and treatment technology by the Ministry of Health. The neurology department of the First Affiliated Hospital of Nanjing Medical University now has two wards (70 beds), outpatient department, emergency department, neurophysiology laboratory and clinical neurology laboratory (cerebrospinal fluid cell laboratory). Every year, patients with various nervous system problems are treated 1000 cases, more than 70,000 cases are treated in outpatient department, and nearly 1000 cases are rescued in emergency. This subject has rich clinical experience in the diagnosis and treatment of various diseases of the nervous system, especially in the first aid of stroke patients, which has many remarkable characteristics. Responsible for the formulation and implementation of the green channel process, stroke first aid specification and key technical scheme of stroke first aid in the major bidding project of Jiangsu Province "Demonstration Research on the Application of Key Technologies of Stroke First Aid" (BS2006007). A large number of intractable diseases have been successfully diagnosed and treated. At present, the subject can carry out routine EEG, dynamic EEG, cerebral blood flow ultrasonic detection, electromyography (including single fiber electromyography), evoked potential, transcranial magnetic stimulation diagnosis and treatment and other technologies. In addition, new technologies such as real-time detection of intracranial pressure and cerebellar fastigial nucleus stimulation have been developed. Some technologies have advanced domestic level. The total value of equipment and instruments is more than 4 million yuan, which effectively meets the clinical medical needs and ensures the high-quality specialized medical level.
At present, the discipline has excellent academic echelon and stable research direction. He has undertaken and participated in more than 20 national, provincial and ministerial scientific research projects, published more than 30 papers at home and abroad every year, and won more than 20 national, provincial and ministerial awards. The main research directions include: pathogenesis and treatment of ischemic cerebrovascular disease, etiological diagnosis and technical research of central nervous system infection, standardized diagnosis and treatment of headache, methods and techniques of central nervous system injury and repair, clinical characteristics of Alzheimer's disease and application of medical methods and techniques. It has trained more than 50 doctors and masters, and is an important training base for senior professionals in Jiangsu Province.